Stock data
| Market cap. | £35.3m |
| Last close | 8.37p |
| High / Low (52 weeks) | 17.8p / 8.4p |
| Stock market listing | ASX, AIM |
| Forecast net debt (m) | N/A |
| Forecast gearing ratio (%) | N/A |
| Team | Resources - Mining |
| Sector | Mining |
Price performance
| % | 1m | 3m | 12m |
|---|---|---|---|
| Actual | (34.31) | (51.45) | N/A |
| Relative * | (31.09) | (47.46) | N/A |
* % Relative to local index
Other companies covered in sector
| Y/E Jun | Revenue (A$m) | EBITDA (A$m) | PBT (A$m) | EPS (fd) (c) | P/E (x) | P/CF (x) |
|---|---|---|---|---|---|---|
| 2010A | 0.0 | (13.1) | (25.5) | (1.3) | N/A | 157.7 |
| 2011A | 50.8 | (8.8) | (23.7) | (0.5) | N/A | 98.4 |
| 2012E | N/A | N/A | N/A | N/A | N/A | N/A |
| 2013E | N/A | N/A | N/A | N/A | N/A | N/A |
Last updated on 17/04/2012
Latest research
Strong H112 results
Update | Mining | 06/03/2012
De Wittekrans BFS
Flash note | Mining | 30/11/2011
Comeback coal
Update | Mining | 22/03/2011
New coal on the block
Outlook | Mining | 07/12/2010
Investment summary
Continental Coal recently released upbeat semi-annual operating and financial results, posting its maiden positive EBITDA and after-tax profit. In the six months to December 2011, the company saw a 112% y-o-y increase in ROM coal output, with export coal sales skyrocketing 380% and revenue rising 284% to A$49.9m. Along with the stellar top-line performance, the company showed stringent cost control, which supported positive EBITDA of A$3.0m compared to a A$28.5m loss in H110. In unit terms, revenue grew 4% y-o-y, while cash COGS fell 18%. Below the gross profit line, the company reduced the consultants’ fees by 78% and financing costs by 82%, which helped it to break even at the bottom line. In all, these results reflect the company’s success in streamlining its thermal coal business and should be further supportive of the stock.
Last updated on 23/04/2012
Industry outlook
We expect thermal coal prices to remain under moderate pressure on the back of the weak global economy.
Last updated on 23/04/2012
Key management
| Andrew Macaulay, Chairman |
| Lodewyk Turvey, CEO |
| Bruce Buthelezi, MD |
Company address
| Ground Floor 1 Havelock Street West Perth WA 6005 Australia 08 9488 5220 View website |